Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

GLAUKOS Corp(GKOS US)

$233.04-5.572.33%Ext:$232.56-0.480.21%(Market Closed ยท 00:59:07 UTC)
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

GLAUKOS Corp(GKOS US)

$233.04-5.572.33%Ext:$232.56-0.480.21%(Market Closed ยท 00:59:07 UTC)
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
GKOS USโ€‹
Ask AI
GKOS USโ€‹
Ask AI

SEC Filings

SEC Filings

Financials(46)

Expand
  • 10-QQ3ended 30 Sept 202628 Oct
  • 10-QQ2ended 30 Jun 202629 Jul
  • 10-QQ1ended 31 Mar 202629 Apr
  • 10-KFY 2025ended 31 Dec 202520 Feb
  • 10-QQ3ended 30 Sept 202531 Oct 2025
  • 10-QQ2ended 30 Jun 20254 Aug 2025
  • 10-QQ1ended 31 Mar 20251 May 2025
  • 10-KFY 2024ended 31 Dec 202425 Feb 2025
  • 10-QQ3ended 30 Sept 20245 Nov 2024
  • 10-QQ2ended 30 Jun 20242 Aug 2024
  • 10-QQ1ended 31 Mar 20243 May 2024
  • 10-KFY 2023ended 31 Dec 202323 Feb 2024
  • 10-QQ3ended 30 Sept 20231 Nov 2023
  • 10-QQ2ended 30 Jun 20232 Aug 2023
  • 10-QQ1ended 31 Mar 20234 May 2023

Events(146)

Expand
  • 8-KResults of Operations and Financial Condition28 Oct
  • 8-KRegulation FD Disclosure3 Aug
  • 8-KResults of Operations and Financial Condition29 Jul
  • 8-KSubmission of Matters to a Vote of Security Holders3 Jun
  • 8-KRegulation FD Disclosure4 May
  • 8-KResults of Operations and Financial Condition29 Apr
  • 8-KRegulation FD Disclosure2 Mar
  • 8-Kโ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹ โ€‹ โ€‹Three Months Endedโ€‹Year Endedโ€‹โ€‹December 31,โ€‹December 31,โ€‹โ€‹2025โ€‹2024โ€‹2025โ€‹2024Net salesโ€‹$143,121โ€‹ โ€‹ โ€‹$105,499โ€‹ โ€‹ โ€‹$507,442โ€‹ โ€‹ โ€‹$383,481Cost of salesโ€‹โ€‹31,771โ€‹โ€‹28,635โ€‹โ€‹111,814โ€‹โ€‹94,027Impairment of intangible assetโ€‹โ€‹112,867โ€‹โ€‹โ€”โ€‹โ€‹112,867โ€‹โ€‹โ€”Gross profitโ€‹โ€‹(1,517)โ€‹โ€‹76,864โ€‹โ€‹282,761โ€‹โ€‹289,454Operating expenses:โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Selling, general and administrativeโ€‹โ€‹94,700โ€‹โ€‹69,003โ€‹โ€‹331,747โ€‹โ€‹261,166Research and developmentโ€‹โ€‹43,651โ€‹โ€‹36,527โ€‹โ€‹150,614โ€‹โ€‹136,425Acquired in-process research and developmentโ€‹โ€‹โ€”โ€‹โ€‹โ€”โ€‹โ€‹โ€”โ€‹โ€‹14,229Total operating expensesโ€‹โ€‹138,351โ€‹โ€‹105,530โ€‹โ€‹482,361โ€‹โ€‹411,820Loss from operationsโ€‹โ€‹(139,868)โ€‹โ€‹(28,666)โ€‹โ€‹(199,600)โ€‹โ€‹(122,366)Non-operating income (expense):โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Interest incomeโ€‹โ€‹2,512โ€‹โ€‹2,494โ€‹โ€‹10,714โ€‹โ€‹11,105Interest expenseโ€‹โ€‹(1,146)โ€‹โ€‹(1,572)โ€‹โ€‹(4,635)โ€‹โ€‹(10,040)Charges associated with convertible senior notesโ€‹โ€‹โ€”โ€‹โ€‹โ€”โ€‹โ€‹โ€”โ€‹โ€‹(18,012)Other (expense) income, netโ€‹โ€‹(1,314)โ€‹โ€‹(5,950)โ€‹โ€‹479โ€‹โ€‹(6,288)Total non-operating income (expense)โ€‹โ€‹52โ€‹โ€‹(5,028)โ€‹โ€‹6,558โ€‹โ€‹(23,235)Loss before taxesโ€‹โ€‹(139,816)โ€‹โ€‹(33,694)โ€‹โ€‹(193,042)โ€‹โ€‹(145,601)Income tax (benefit) provisionโ€‹โ€‹(6,159)โ€‹โ€‹(114)โ€‹โ€‹(5,351)โ€‹โ€‹771Net lossโ€‹$(133,657)โ€‹$(33,580)โ€‹$(187,691)โ€‹$(146,372)โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Basic and diluted net loss per shareโ€‹$(2.32)โ€‹$(0.60)โ€‹$(3.28)โ€‹$(2.77)โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Weighted-average shares outstanding used to compute basic and diluted net loss per shareโ€‹โ€‹57,506โ€‹โ€‹55,584โ€‹โ€‹57,190โ€‹โ€‹52,75517 Feb
  • 8-KResults of Operations and Financial Condition13 Jan
  • 8-KRegulation FD Disclosure10 Nov 2025
  • 8-Kโ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Three Months Endedโ€‹Nine Months Endedโ€‹โ€‹September 30,โ€‹September 30,โ€‹2025202420252024Net salesโ€‹$133,537โ€‹$96,670โ€‹$364,321โ€‹$277,982Cost of salesโ€‹28,831โ€‹22,584โ€‹80,043โ€‹65,392Gross profitโ€‹104,706โ€‹74,086โ€‹284,278โ€‹212,590Operating expenses:โ€‹โ€‹โ€‹โ€‹Selling, general and administrativeโ€‹82,999โ€‹64,000โ€‹237,047โ€‹192,163Research and developmentโ€‹38,072โ€‹34,746โ€‹106,963โ€‹99,898Acquired in-process research and developmentโ€‹โ€”โ€‹โ€”โ€‹โ€”โ€‹14,229Total operating expensesโ€‹121,071โ€‹98,746โ€‹344,010โ€‹306,290Loss from operationsโ€‹(16,365)โ€‹(24,660)โ€‹(59,732)โ€‹(93,700)Non-operating income (expense):โ€‹โ€‹โ€‹โ€‹Interest incomeโ€‹2,552โ€‹2,700โ€‹8,202โ€‹8,611Interest expenseโ€‹(1,175)โ€‹(1,663)โ€‹(3,489)โ€‹(8,468)Charges associated with convertible senior notesโ€‹โ€”โ€‹โ€”โ€‹โ€”โ€‹(18,012)Other (expense) income, netโ€‹(1,009)โ€‹2,391โ€‹1,793โ€‹(338)Total non-operating income (expense)โ€‹368โ€‹3,428โ€‹6,506โ€‹(18,207)Loss before taxesโ€‹(15,997)โ€‹(21,232)โ€‹(53,226)โ€‹(111,907)Income tax provisionโ€‹234โ€‹177โ€‹808โ€‹885Net lossโ€‹$(16,231)โ€‹$(21,409)โ€‹$(54,034)โ€‹$(112,792)โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Basic and diluted net loss per shareโ€‹$(0.28)โ€‹$(0.39)โ€‹$(0.95)โ€‹$(2.18)โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Weighted-average shares outstanding used to compute basic and diluted net loss per shareโ€‹57,398โ€‹55,037โ€‹57,083โ€‹51,80429 Oct 2025
  • 8-KRegulation FD Disclosure12 Aug 2025
  • 8-Kโ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Three Months EndedSix Months Endedโ€‹โ€‹June 30,โ€‹June 30,โ€‹โ€‹20252024โ€‹20252024Net salesโ€‹$124,120โ€‹$95,690โ€‹$230,784โ€‹$181,312Cost of salesโ€‹โ€‹26,896โ€‹โ€‹22,550โ€‹โ€‹51,212โ€‹โ€‹42,808Gross profitโ€‹โ€‹97,224โ€‹โ€‹73,140โ€‹โ€‹179,572โ€‹โ€‹138,504Operating expenses:โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Selling, general and administrativeโ€‹โ€‹83,375โ€‹โ€‹66,188โ€‹โ€‹154,048โ€‹โ€‹128,163Research and developmentโ€‹โ€‹36,538โ€‹โ€‹34,426โ€‹โ€‹68,891โ€‹โ€‹65,152Acquired in-process research and developmentโ€‹โ€‹โ€”โ€‹โ€‹2,500โ€‹โ€‹โ€”โ€‹โ€‹14,229Total operating expensesโ€‹โ€‹119,913โ€‹โ€‹103,114โ€‹โ€‹222,939โ€‹โ€‹207,544Loss from operationsโ€‹โ€‹(22,689)โ€‹โ€‹(29,974)โ€‹โ€‹(43,367)โ€‹โ€‹(69,040)Non-operating income (expense):โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Interest incomeโ€‹โ€‹2,574โ€‹โ€‹2,828โ€‹โ€‹5,650โ€‹โ€‹5,911Interest expenseโ€‹โ€‹(1,151)โ€‹โ€‹(3,355)โ€‹โ€‹(2,314)โ€‹โ€‹(6,805)Charges associated with convertible senior notesโ€‹โ€‹โ€”โ€‹โ€‹(18,012)โ€‹โ€‹โ€”โ€‹โ€‹(18,012)Other income (expense), netโ€‹โ€‹1,857โ€‹โ€‹(1,701)โ€‹โ€‹2,802โ€‹โ€‹(2,729)Total non-operating income (expense)โ€‹โ€‹3,280โ€‹โ€‹(20,240)โ€‹โ€‹6,138โ€‹โ€‹(21,635)Loss before taxesโ€‹โ€‹(19,409)โ€‹โ€‹(50,214)โ€‹โ€‹(37,229)โ€‹โ€‹(90,675)Income tax provisionโ€‹โ€‹248โ€‹โ€‹331โ€‹โ€‹574โ€‹โ€‹708Net lossโ€‹$(19,657)โ€‹$(50,545)โ€‹$(37,803)โ€‹$(91,383)โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Basic and diluted net loss per shareโ€‹$(0.34)โ€‹$(1.00)โ€‹$(0.66)โ€‹$(1.82)โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Weighted-average shares outstanding used to compute basic and diluted net loss per shareโ€‹โ€‹57,205โ€‹โ€‹50,715โ€‹โ€‹56,922โ€‹โ€‹50,16930 Jul 2025
  • 8-KSubmission of Matters to Shareholder Vote3 Jun 2025
  • 8-KRegulation FD Disclosure14 May 2025

Insider Ownership(574)

Expand
  • 4Statement of changes in beneficial ownership3 Nov
  • 4Statement of changes in beneficial ownership3 Nov
  • 4Statement of changes in beneficial ownership3 Nov
  • 4Statement of changes in beneficial ownership7 Oct
  • 4Statement of changes in beneficial ownership28 Sep
  • 4Statement of changes in beneficial ownership18 Sep
  • 4Statement of changes in beneficial ownership1 Sep
  • 4Kliman Gilbert H20 Aug
  • 4Gilliam Joseph E13 Aug
  • 4Thurman Alex R.11 Aug
  • 4WEN LEANA3 Aug
  • 4Thurman Alex R.21 Jul
  • 4Thurman Alex R.13 Jul
  • 4Thurman Alex R.8 Jul
  • 4Navratil Tomas8 Jul

Beneficial Ownership(94)

Expand
  • SC 13G/AGLAUKOS Corp15 May
  • SC 13GGLAUKOS Corp29 Apr
  • SC 13GGLAUKOS Corp29 Apr
  • SC 13G/AGLAUKOS Corp26 Mar
  • SC 13GGLAUKOS Corp17 Feb
  • SC 13GGLAUKOS Corp11 Feb
  • SC 13G/AGLAUKOS Corp10 Feb
  • SC 13GGLAUKOS Corp12 Aug 2025
  • SC 13G/AGLAUKOS Corp7 Aug 2025
  • SC 13G/AGLAUKOS Corp29 Apr 2025
  • SC 13G/AGLAUKOS Corp12 Feb 2025
  • SC 13G/AGLAUKOS Corp12 Feb 2025
  • SC 13G/AGLAUKOS Corp14 Nov 2024
  • SC 13G/AGLAUKOS Corp14 Feb 2024
  • SC 13G/AGLAUKOS Corp13 Feb 2024

Other Ownership(112)

Expand
  • 144Navratil Tomas30 Oct
  • 144Navratil Tomas5 Oct
  • 144Navratil Tomas25 Sep
  • 144Navratil Tomas16 Sep
  • 144Navratil Tomas28 Aug
  • 144Kliman Gilbert H19 Aug
  • 144Gilliam Joseph E11 Aug
  • 144Thurman Alex R.7 Aug
  • 144WEN LEANA31 Jul
  • 144Thurman Alex R.16 Jul
  • 144Thurman Alex R.9 Jul
  • 144Thurman Alex R.6 Jul
  • 144Navratil Tomas1 Jul
  • 144Navratil Tomas16 Jun
  • 144Kliman Gilbert H14 May

Proxies(25)

Expand
  • ARSAnnual report to security holders16 Apr
  • DEFA14ADefinitive additional materials16 Apr
  • DEF 14ADefinitive proxy statement16 Apr
  • DEF 14ADefinitive proxy statement15 Apr 2025
  • ARSAnnual report to security holders15 Apr 2025
  • DEFA14ADefinitive additional materials15 Apr 2025
  • ARSAnnual report to security holders16 Apr 2024
  • DEFA14ADefinitive additional materials16 Apr 2024
  • DEF 14ADefinitive proxy statement16 Apr 2024
  • ARSAnnual report to security holders18 Apr 2023
  • DEF 14ADefinitive proxy statement18 Apr 2023
  • DEFA14ADefinitive additional materials18 Apr 2023
  • DEFA14ADefinitive additional materials19 Apr 2022
  • DEF 14ADefinitive proxy statement19 Apr 2022
  • DEF 14ADefinitive proxy statement22 Apr 2021

Registrations(36)

Expand
  • S-8Registration statement (employee benefit plan)24 Feb
  • S-8Registration statement (employee benefit plan)20 Aug 2025
  • S-8Registration statement (employee benefit plan)15 Mar 2024
  • S-8Registration statement (employee benefit plan)10 Mar 2023
  • S-8Registration statement (employee benefit plan)8 Mar 2022
  • S-8Registration statement (employee benefit plan)11 Mar 2021
  • S-8Registration statement (employee benefit plan)9 Mar 2020
  • S-8 POSPost-effective amendment (employee benefit plan)21 Nov 2019
  • 425Business combination communication14 Nov 2019
  • 425Business combination communication7 Nov 2019
  • 425Business combination communication7 Nov 2019
  • 424B3Prospectus filing (Rule 424(b)(3))17 Oct 2019
  • S-4/ARegistration statement (business combination, amendment)15 Oct 2019
  • S-4Registration statement (business combination)17 Sep 2019
  • 425Business combination communication5 Sep 2019

Filing Review Correspondence(9)

Expand
  • CORRESPFiling review correspondence23 Apr 2020
  • CORRESPFiling review correspondence15 Oct 2019
  • CORRESPFiling review correspondence15 Oct 2019
  • UPLOADFiling review upload9 Oct 2019
  • CORRESPFiling review correspondence23 Jun 2015
  • CORRESPFiling review correspondence23 Jun 2015
  • CORRESPFiling review correspondence8 Jun 2015
  • CORRESPFiling review correspondence1 Jun 2015
  • CORRESPFiling review correspondence12 May 2015

SEC Orders And Notices(2)

Expand
  • EFFECTNotice of effectiveness17 Oct 2019
  • EFFECTNotice of effectiveness24 Jun 2015

Exempt Offerings(5)

Expand
  • DNotice of exempt offering of securities (Reg D)25 Jan 2013
  • DNotice of exempt offering of securities (Reg D)3 Oct 2012
  • DNotice of exempt offering of securities (Reg D)10 Aug 2012
  • DNotice of exempt offering of securities (Reg D)1 Feb 2011
  • DNotice of exempt offering of securities (Reg D)23 Sep 2010

Other(10)

Expand
  • SDSD29 May
  • SDSD30 May 2025
  • SDSD30 May 2024
  • SDSD31 May 2023
  • SDSD27 May 2022
  • SDSD28 May 2021
  • SDSD29 May 2020
  • SDSD30 May 2019
  • SDSD31 May 2018
  • CERTNYSAUTO-GENERATED PAPER DOCUMENT22 Jun 2015

Financials(46)

Expand
  • 10-QQ3ended 30 Sept 202628 Oct
  • 10-QQ2ended 30 Jun 202629 Jul
  • 10-QQ1ended 31 Mar 202629 Apr
  • 10-KFY 2025ended 31 Dec 202520 Feb
  • 10-QQ3ended 30 Sept 202531 Oct 2025
  • 10-QQ2ended 30 Jun 20254 Aug 2025
  • 10-QQ1ended 31 Mar 20251 May 2025
  • 10-KFY 2024ended 31 Dec 202425 Feb 2025
  • 10-QQ3ended 30 Sept 20245 Nov 2024
  • 10-QQ2ended 30 Jun 20242 Aug 2024
  • 10-QQ1ended 31 Mar 20243 May 2024
  • 10-KFY 2023ended 31 Dec 202323 Feb 2024
  • 10-QQ3ended 30 Sept 20231 Nov 2023
  • 10-QQ2ended 30 Jun 20232 Aug 2023
  • 10-QQ1ended 31 Mar 20234 May 2023

Events(146)

Expand
  • 8-KResults of Operations and Financial Condition28 Oct
  • 8-KRegulation FD Disclosure3 Aug
  • 8-KResults of Operations and Financial Condition29 Jul
  • 8-KSubmission of Matters to a Vote of Security Holders3 Jun
  • 8-KRegulation FD Disclosure4 May
  • 8-KResults of Operations and Financial Condition29 Apr
  • 8-KRegulation FD Disclosure2 Mar
  • 8-Kโ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹ โ€‹ โ€‹Three Months Endedโ€‹Year Endedโ€‹โ€‹December 31,โ€‹December 31,โ€‹โ€‹2025โ€‹2024โ€‹2025โ€‹2024Net salesโ€‹$143,121โ€‹ โ€‹ โ€‹$105,499โ€‹ โ€‹ โ€‹$507,442โ€‹ โ€‹ โ€‹$383,481Cost of salesโ€‹โ€‹31,771โ€‹โ€‹28,635โ€‹โ€‹111,814โ€‹โ€‹94,027Impairment of intangible assetโ€‹โ€‹112,867โ€‹โ€‹โ€”โ€‹โ€‹112,867โ€‹โ€‹โ€”Gross profitโ€‹โ€‹(1,517)โ€‹โ€‹76,864โ€‹โ€‹282,761โ€‹โ€‹289,454Operating expenses:โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Selling, general and administrativeโ€‹โ€‹94,700โ€‹โ€‹69,003โ€‹โ€‹331,747โ€‹โ€‹261,166Research and developmentโ€‹โ€‹43,651โ€‹โ€‹36,527โ€‹โ€‹150,614โ€‹โ€‹136,425Acquired in-process research and developmentโ€‹โ€‹โ€”โ€‹โ€‹โ€”โ€‹โ€‹โ€”โ€‹โ€‹14,229Total operating expensesโ€‹โ€‹138,351โ€‹โ€‹105,530โ€‹โ€‹482,361โ€‹โ€‹411,820Loss from operationsโ€‹โ€‹(139,868)โ€‹โ€‹(28,666)โ€‹โ€‹(199,600)โ€‹โ€‹(122,366)Non-operating income (expense):โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Interest incomeโ€‹โ€‹2,512โ€‹โ€‹2,494โ€‹โ€‹10,714โ€‹โ€‹11,105Interest expenseโ€‹โ€‹(1,146)โ€‹โ€‹(1,572)โ€‹โ€‹(4,635)โ€‹โ€‹(10,040)Charges associated with convertible senior notesโ€‹โ€‹โ€”โ€‹โ€‹โ€”โ€‹โ€‹โ€”โ€‹โ€‹(18,012)Other (expense) income, netโ€‹โ€‹(1,314)โ€‹โ€‹(5,950)โ€‹โ€‹479โ€‹โ€‹(6,288)Total non-operating income (expense)โ€‹โ€‹52โ€‹โ€‹(5,028)โ€‹โ€‹6,558โ€‹โ€‹(23,235)Loss before taxesโ€‹โ€‹(139,816)โ€‹โ€‹(33,694)โ€‹โ€‹(193,042)โ€‹โ€‹(145,601)Income tax (benefit) provisionโ€‹โ€‹(6,159)โ€‹โ€‹(114)โ€‹โ€‹(5,351)โ€‹โ€‹771Net lossโ€‹$(133,657)โ€‹$(33,580)โ€‹$(187,691)โ€‹$(146,372)โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Basic and diluted net loss per shareโ€‹$(2.32)โ€‹$(0.60)โ€‹$(3.28)โ€‹$(2.77)โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Weighted-average shares outstanding used to compute basic and diluted net loss per shareโ€‹โ€‹57,506โ€‹โ€‹55,584โ€‹โ€‹57,190โ€‹โ€‹52,75517 Feb
  • 8-KResults of Operations and Financial Condition13 Jan
  • 8-KRegulation FD Disclosure10 Nov 2025
  • 8-Kโ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Three Months Endedโ€‹Nine Months Endedโ€‹โ€‹September 30,โ€‹September 30,โ€‹2025202420252024Net salesโ€‹$133,537โ€‹$96,670โ€‹$364,321โ€‹$277,982Cost of salesโ€‹28,831โ€‹22,584โ€‹80,043โ€‹65,392Gross profitโ€‹104,706โ€‹74,086โ€‹284,278โ€‹212,590Operating expenses:โ€‹โ€‹โ€‹โ€‹Selling, general and administrativeโ€‹82,999โ€‹64,000โ€‹237,047โ€‹192,163Research and developmentโ€‹38,072โ€‹34,746โ€‹106,963โ€‹99,898Acquired in-process research and developmentโ€‹โ€”โ€‹โ€”โ€‹โ€”โ€‹14,229Total operating expensesโ€‹121,071โ€‹98,746โ€‹344,010โ€‹306,290Loss from operationsโ€‹(16,365)โ€‹(24,660)โ€‹(59,732)โ€‹(93,700)Non-operating income (expense):โ€‹โ€‹โ€‹โ€‹Interest incomeโ€‹2,552โ€‹2,700โ€‹8,202โ€‹8,611Interest expenseโ€‹(1,175)โ€‹(1,663)โ€‹(3,489)โ€‹(8,468)Charges associated with convertible senior notesโ€‹โ€”โ€‹โ€”โ€‹โ€”โ€‹(18,012)Other (expense) income, netโ€‹(1,009)โ€‹2,391โ€‹1,793โ€‹(338)Total non-operating income (expense)โ€‹368โ€‹3,428โ€‹6,506โ€‹(18,207)Loss before taxesโ€‹(15,997)โ€‹(21,232)โ€‹(53,226)โ€‹(111,907)Income tax provisionโ€‹234โ€‹177โ€‹808โ€‹885Net lossโ€‹$(16,231)โ€‹$(21,409)โ€‹$(54,034)โ€‹$(112,792)โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Basic and diluted net loss per shareโ€‹$(0.28)โ€‹$(0.39)โ€‹$(0.95)โ€‹$(2.18)โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Weighted-average shares outstanding used to compute basic and diluted net loss per shareโ€‹57,398โ€‹55,037โ€‹57,083โ€‹51,80429 Oct 2025
  • 8-KRegulation FD Disclosure12 Aug 2025
  • 8-Kโ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Three Months EndedSix Months Endedโ€‹โ€‹June 30,โ€‹June 30,โ€‹โ€‹20252024โ€‹20252024Net salesโ€‹$124,120โ€‹$95,690โ€‹$230,784โ€‹$181,312Cost of salesโ€‹โ€‹26,896โ€‹โ€‹22,550โ€‹โ€‹51,212โ€‹โ€‹42,808Gross profitโ€‹โ€‹97,224โ€‹โ€‹73,140โ€‹โ€‹179,572โ€‹โ€‹138,504Operating expenses:โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Selling, general and administrativeโ€‹โ€‹83,375โ€‹โ€‹66,188โ€‹โ€‹154,048โ€‹โ€‹128,163Research and developmentโ€‹โ€‹36,538โ€‹โ€‹34,426โ€‹โ€‹68,891โ€‹โ€‹65,152Acquired in-process research and developmentโ€‹โ€‹โ€”โ€‹โ€‹2,500โ€‹โ€‹โ€”โ€‹โ€‹14,229Total operating expensesโ€‹โ€‹119,913โ€‹โ€‹103,114โ€‹โ€‹222,939โ€‹โ€‹207,544Loss from operationsโ€‹โ€‹(22,689)โ€‹โ€‹(29,974)โ€‹โ€‹(43,367)โ€‹โ€‹(69,040)Non-operating income (expense):โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Interest incomeโ€‹โ€‹2,574โ€‹โ€‹2,828โ€‹โ€‹5,650โ€‹โ€‹5,911Interest expenseโ€‹โ€‹(1,151)โ€‹โ€‹(3,355)โ€‹โ€‹(2,314)โ€‹โ€‹(6,805)Charges associated with convertible senior notesโ€‹โ€‹โ€”โ€‹โ€‹(18,012)โ€‹โ€‹โ€”โ€‹โ€‹(18,012)Other income (expense), netโ€‹โ€‹1,857โ€‹โ€‹(1,701)โ€‹โ€‹2,802โ€‹โ€‹(2,729)Total non-operating income (expense)โ€‹โ€‹3,280โ€‹โ€‹(20,240)โ€‹โ€‹6,138โ€‹โ€‹(21,635)Loss before taxesโ€‹โ€‹(19,409)โ€‹โ€‹(50,214)โ€‹โ€‹(37,229)โ€‹โ€‹(90,675)Income tax provisionโ€‹โ€‹248โ€‹โ€‹331โ€‹โ€‹574โ€‹โ€‹708Net lossโ€‹$(19,657)โ€‹$(50,545)โ€‹$(37,803)โ€‹$(91,383)โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Basic and diluted net loss per shareโ€‹$(0.34)โ€‹$(1.00)โ€‹$(0.66)โ€‹$(1.82)โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹โ€‹Weighted-average shares outstanding used to compute basic and diluted net loss per shareโ€‹โ€‹57,205โ€‹โ€‹50,715โ€‹โ€‹56,922โ€‹โ€‹50,16930 Jul 2025
  • 8-KSubmission of Matters to Shareholder Vote3 Jun 2025
  • 8-KRegulation FD Disclosure14 May 2025

Insider Ownership(574)

Expand
  • 4Statement of changes in beneficial ownership3 Nov
  • 4Statement of changes in beneficial ownership3 Nov
  • 4Statement of changes in beneficial ownership3 Nov
  • 4Statement of changes in beneficial ownership7 Oct
  • 4Statement of changes in beneficial ownership28 Sep
  • 4Statement of changes in beneficial ownership18 Sep
  • 4Statement of changes in beneficial ownership1 Sep
  • 4Kliman Gilbert H20 Aug
  • 4Gilliam Joseph E13 Aug
  • 4Thurman Alex R.11 Aug
  • 4WEN LEANA3 Aug
  • 4Thurman Alex R.21 Jul
  • 4Thurman Alex R.13 Jul
  • 4Thurman Alex R.8 Jul
  • 4Navratil Tomas8 Jul

Beneficial Ownership(94)

Expand
  • SC 13G/AGLAUKOS Corp15 May
  • SC 13GGLAUKOS Corp29 Apr
  • SC 13GGLAUKOS Corp29 Apr
  • SC 13G/AGLAUKOS Corp26 Mar
  • SC 13GGLAUKOS Corp17 Feb
  • SC 13GGLAUKOS Corp11 Feb
  • SC 13G/AGLAUKOS Corp10 Feb
  • SC 13GGLAUKOS Corp12 Aug 2025
  • SC 13G/AGLAUKOS Corp7 Aug 2025
  • SC 13G/AGLAUKOS Corp29 Apr 2025
  • SC 13G/AGLAUKOS Corp12 Feb 2025
  • SC 13G/AGLAUKOS Corp12 Feb 2025
  • SC 13G/AGLAUKOS Corp14 Nov 2024
  • SC 13G/AGLAUKOS Corp14 Feb 2024
  • SC 13G/AGLAUKOS Corp13 Feb 2024

Other Ownership(112)

Expand
  • 144Navratil Tomas30 Oct
  • 144Navratil Tomas5 Oct
  • 144Navratil Tomas25 Sep
  • 144Navratil Tomas16 Sep
  • 144Navratil Tomas28 Aug
  • 144Kliman Gilbert H19 Aug
  • 144Gilliam Joseph E11 Aug
  • 144Thurman Alex R.7 Aug
  • 144WEN LEANA31 Jul
  • 144Thurman Alex R.16 Jul
  • 144Thurman Alex R.9 Jul
  • 144Thurman Alex R.6 Jul
  • 144Navratil Tomas1 Jul
  • 144Navratil Tomas16 Jun
  • 144Kliman Gilbert H14 May

Proxies(25)

Expand
  • ARSAnnual report to security holders16 Apr
  • DEFA14ADefinitive additional materials16 Apr
  • DEF 14ADefinitive proxy statement16 Apr
  • DEF 14ADefinitive proxy statement15 Apr 2025
  • ARSAnnual report to security holders15 Apr 2025
  • DEFA14ADefinitive additional materials15 Apr 2025
  • ARSAnnual report to security holders16 Apr 2024
  • DEFA14ADefinitive additional materials16 Apr 2024
  • DEF 14ADefinitive proxy statement16 Apr 2024
  • ARSAnnual report to security holders18 Apr 2023
  • DEF 14ADefinitive proxy statement18 Apr 2023
  • DEFA14ADefinitive additional materials18 Apr 2023
  • DEFA14ADefinitive additional materials19 Apr 2022
  • DEF 14ADefinitive proxy statement19 Apr 2022
  • DEF 14ADefinitive proxy statement22 Apr 2021

Registrations(36)

Expand
  • S-8Registration statement (employee benefit plan)24 Feb
  • S-8Registration statement (employee benefit plan)20 Aug 2025
  • S-8Registration statement (employee benefit plan)15 Mar 2024
  • S-8Registration statement (employee benefit plan)10 Mar 2023
  • S-8Registration statement (employee benefit plan)8 Mar 2022
  • S-8Registration statement (employee benefit plan)11 Mar 2021
  • S-8Registration statement (employee benefit plan)9 Mar 2020
  • S-8 POSPost-effective amendment (employee benefit plan)21 Nov 2019
  • 425Business combination communication14 Nov 2019
  • 425Business combination communication7 Nov 2019
  • 425Business combination communication7 Nov 2019
  • 424B3Prospectus filing (Rule 424(b)(3))17 Oct 2019
  • S-4/ARegistration statement (business combination, amendment)15 Oct 2019
  • S-4Registration statement (business combination)17 Sep 2019
  • 425Business combination communication5 Sep 2019

Filing Review Correspondence(9)

Expand
  • CORRESPFiling review correspondence23 Apr 2020
  • CORRESPFiling review correspondence15 Oct 2019
  • CORRESPFiling review correspondence15 Oct 2019
  • UPLOADFiling review upload9 Oct 2019
  • CORRESPFiling review correspondence23 Jun 2015
  • CORRESPFiling review correspondence23 Jun 2015
  • CORRESPFiling review correspondence8 Jun 2015
  • CORRESPFiling review correspondence1 Jun 2015
  • CORRESPFiling review correspondence12 May 2015

SEC Orders And Notices(2)

Expand
  • EFFECTNotice of effectiveness17 Oct 2019
  • EFFECTNotice of effectiveness24 Jun 2015

Exempt Offerings(5)

Expand
  • DNotice of exempt offering of securities (Reg D)25 Jan 2013
  • DNotice of exempt offering of securities (Reg D)3 Oct 2012
  • DNotice of exempt offering of securities (Reg D)10 Aug 2012
  • DNotice of exempt offering of securities (Reg D)1 Feb 2011
  • DNotice of exempt offering of securities (Reg D)23 Sep 2010

Other(10)

Expand
  • SDSD29 May
  • SDSD30 May 2025
  • SDSD30 May 2024
  • SDSD31 May 2023
  • SDSD27 May 2022
  • SDSD28 May 2021
  • SDSD29 May 2020
  • SDSD30 May 2019
  • SDSD31 May 2018
  • CERTNYSAUTO-GENERATED PAPER DOCUMENT22 Jun 2015